Business News • PR NewsWire • Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

OXFORD, England, November 9, 2016 /PRNewswire/ -- - IMCgp100 Demonstrates Clear Early Evidence of Monotherapy Activity in Patients With Uveal Melanoma - Pivotal Phase II Clinical Study on Track to be Initiated in First Quarter 2017 Immunocore Limited, a world-leading biotechn...

View More : http://www.prnewswire.com/news-releases/immunocore-presents-positive-monotherapy-data-in-uveal-melanoma-at-the-society-f...

Releted News by prnewswire

Mountain RF Sensors, Inc. confirms attendance at the 53rd Annual AOC International Symposium and Convention

TCS Education System Appoints New Chief Financial Officer